89bio, Inc. (ETNB) has a market capitalization of $2.2B and trades at $14.84. The 52-week range is 4.16-15.06.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -4.2, Earnings Per Share (EPS) of $-3.51.
The stock has a beta of 1.26, operates in the Healthcare sector.
